Badshah SL, Ullah A, Ahmad N, Almarhoon ZM, Mabkhot Y. Increasing the strength and production of artemisinin and its derivatives. Molecules 2018, 23(1).

Talman AM, Clain J, Duval R, Ménard R, Ariey F. Artemisinin bioactivity and resistance in malaria parasites. Trends Parasitol. 2019;35(12):953–63.

Article  CAS  PubMed  Google Scholar 

Shi C, Li H, Yang Y, Hou L. Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives. Mediat Inflamm. 2015;2015: 435713.

Article  Google Scholar 

Wang JG, Zhu XX. Advances in the study of artemisinin targets and mechanisms in chemical biology. Kexue Tongbao (Chin Ed). 2017;62(18):1973–81 (in Chinese).

Google Scholar 

Guo HQ, Liu SZ, Wang L, Liu ZY, Wang ZH. Research progress of artemisinin and its derivatives against coccidiosis of chicken. Poult Sci. 2020;04:52–6 (in Chinese).

Google Scholar 

Isba R, Zani B, Gathu M, Sinclair D. Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev. 2015;2015(2): Cd011547.

PubMed  PubMed Central  Google Scholar 

Naing C, Whittaker MA, Mak JW, Aung K. A systematic review of the efficacy of a single dose artemisinin-naphthoquine in treating uncomplicated malaria. Malar J. 2015;14:392.

Article  PubMed  PubMed Central  Google Scholar 

World malaria report 2022. WHO. 2022. https://www.who.int/publications/i/item/9789240064898. Accessed 15 Sep 2023.

Garcia LS. Malaria. Clin Lab Med. 2010;30(1):93–129.

Article  PubMed  Google Scholar 

Ward KE, Fidock DA, Bridgford JL. Plasmodium falciparum resistance to artemisinin-based combination therapies. Curr Opin Microbiol. 2022;69: 102193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Firestone GL, Sundar SN. Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev Mol Med. 2009;11: e32.

Article  PubMed  Google Scholar 

Crespo-Ortiz MP, Wei MQ. Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. J Biomed Biotechnol. 2012;2012: 247597.

Article  PubMed  Google Scholar 

Lai HC, Singh NP, Sasaki T. Development of artemisinin compounds for cancer treatment. Invest New Drugs. 2013;31(1):230–46.

Article  CAS  PubMed  Google Scholar 

Ho WE, Peh HY, Chan TK, Wong WS. Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther. 2014;142(1):126–39.

Article  CAS  PubMed  Google Scholar 

Li Y, Shan NN, Sui XH. Research progress on artemisinin and its derivatives against hematological malignancies. Chin J Integr Med. 2020;26(12):947–55.

Article  CAS  PubMed  Google Scholar 

Wang Y, Wang Y, You F, Xue J. Novel use for old drugs: the emerging role of artemisinin and its derivatives in fibrosis. Pharmacol Res. 2020;157: 104829.

Article  CAS  PubMed  Google Scholar 

Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69.

Article  PubMed  PubMed Central  Google Scholar 

Lam NS, Long X, Su XZ, Lu F. Artemisinin and its derivatives in treating helminthic infections beyond schistosomiasis. Pharmacol Res. 2018;133:77–100.

Article  CAS  PubMed  Google Scholar 

Pérez del Villar L, Burguillo FJ, López-Abán J, Muro A. Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis. PLoS ONE. 2012;7(9): e45867.

Article  PubMed  PubMed Central  Google Scholar 

De Clercq D, Vercruysse J, Kongs A, Verlé P, Dompnier JP, Faye PC. Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren. Acta Trop. 2002;82(1):61–6.

Article  PubMed  Google Scholar 

Boulanger D, Dieng Y, Cisse B, Remoue F, Capuano F, Dieme JL, et al. Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks. Trans R Soc Trop Med Hyg. 2007;101(2):113–6.

Article  CAS  PubMed  Google Scholar 

Goran EK, Jürg U, Gnaka HN, Ahoa Y, Guessan NA, et al. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. Am J Trop Med Hyg. 2003;68(1):24–32.

Article  Google Scholar 

Hua HY, An N, Wu HZ, Gao ZL, Zhang Y, Liang YS. Clinical trials on preventive effect of artesunate against reinfection of Schistosoma japonicum. Zhongguo Xuexichongbing Fangzhi Zazhi. 2010;22(2):150–2 (in Chinese).

Google Scholar 

Xiao S, Shi Z, Zhuo S, Wang C, Zhang Z, Chu B, et al. Field studies on the preventive effect of oral artemether against schistosomal infection. Chin Med J. 1996;109(4):272–5.

CAS  PubMed  Google Scholar 

Song Y, Xiao S, Wu W, Zhang S, Xie H, Xu X, et al. Preventive effect of artemether on schistosome infection. Chin Med J. 1998;111(2):123–7.

CAS  PubMed  Google Scholar 

Li YS, Chen HG, He HB, Hou XY, Ellis M, McManus DP. A double-blind field trial on the effects of artemether on Schistosoma japonicum infection in a highly endemic focus in southern China. Acta Trop. 2005;96(2–3):184–90.

Article  CAS  PubMed  Google Scholar 

Yi ZH, Lu M, Feng DC, Wang ZH, Xiang CP, Gou ZQ, et al. Clinical observation on prevention of schistosomiasis by oral artesunate in people exposed to epidemic water for a short time. Zhongguo Xuexichongbing Fangzhi Zazhi. 2000;2:100–1 (in Chinese).

Google Scholar 

Borrmann S, Szlezák N, Faucher JF, Matsiegui PB, Neubauer R, Binder RK, et al. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. J Infect Dis. 2001;184(10):1363–6.

Article  CAS  PubMed  Google Scholar 

Lin DD, Zhang SJ, Liu YM, Li SW, Wu LJ, Gao ZL, et al. Field observation on the prophylaxis of artesunate with 15 days interval against infection of schtstosoma japonicum. Zhongguo Renshou Gonghuanbing Zazhi. 1999;01:39–40 (in Chinese).

Google Scholar 

Lu RG, Wang XY, Li ZH, Yan JL, Huang YN, Liu ZD, et al. Clinical validation of artesunate against Schistosomiasis japonicum. Jishengchongbing Yu Ganranxingjibing. 1997;01:48 (in Chinese).

Google Scholar 

Xu MS, Zhang SQ, Wang TP, Fang GR, Wang QZ, He JX, et al. Field appliance of oral artesunate for prevention of schistosomiasis japonica. Redaibing Yu Jishengchongxue. 1998;02:68–71 (in Chinese).

Google Scholar 

Liu HY, Li SW. Observation on the prevention of schistosomiasis japonica by administration of artesunate long term. J Pathogen Biol. 1999;012(003):214–5 (in Chinese).

Google Scholar 

Lu GY, Lin GJ, Sun MX, Jiang J, Cui JF, Wu QZ, et al. Optimization of oral artesunate to prevent schistosoma schistosoma infection. J Pathogen Biol. 2000;03:57–9 (in Chinese).

Google Scholar 

Zhang SJ, Lin DD, Liu YM, Liu HY, Liu ZD, Hu LS, et al. Clinical trials on preventive effect of artesunate on Schistosomiasis Japonica. Xiandai Zhenduan Yu Zhiliao. 2000;02:68–72 (in Chinese).

Google Scholar 

Hou XY. Clinical study on acute schistosomiasis japonica treatment with artemether and praziquantel. Master. Central South University; 2006 (in Chinese).

Wu LJ, Li SW, Xuan XY, Xu PS, Liu ZD, Hu LS, et al. Field application of artesunate in prophylaxis of schistosomiasis: an observation of 346 cases. Zhongguo Xuexichongbing Fangzhi Zazhi. 1995;06:323–7 (in Chinese).

Google Scholar 

Liu ZD, Hu F, Zhou SY, Liu YM, Hu LS, Su LH, et al. Clinical validation of artesunate against Schistosomiasis japonicum in Rocky Mountains. Zhongguo Xuexichongbing Fangzhi Zazhi. 1996;03:142–5 (in Chinese).

Google Scholar 

N’Goran EK, Utzinger J, Gnaka HN, Yapi A, N’Guessan NA, Kigbafori SD, et al. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. Am J Trop Med Hyg. 2003;68(1):24–32.

Article  CAS  PubMed  Google Scholar 

Utzinger J, N’Goran EK, N’Dri A, Lengeler C, Xiao S, Tanner M. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet. 2000;355(9212):1320–5.

Article  CAS  PubMed  Google Scholar 

Hua HY, Liang YS, Zhang Y, Wei JF, Guo HX. The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China. J Parasitol Res. 2010;107(4):873–8.

Article  Google Scholar 

Liu R, Dong HF, Jiang MS. The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China? Parasitol Res. 2012;110(4):1563–4.

Article  PubMed  Google Scholar 

Sissoko MS, Dabo A, Traoré H, Diallo M, Traoré B, Konaté D, et al. Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS ONE. 2009. https://doi.org/10.1371/journal.pone.0006732.

Article  PubMed  PubMed Central  Google Scholar 

Wang DG, Wang GH, Wang HL, Wang B, Xu AR, Li XS, et al. A control study of artemether auxiliary treatment for schizophrenia with toxoplasmosis gondii antibody positive. Linchuang Xinshen Jibing Zazhi. 2012;18(2):103–5 (in Chinese).

Google Scholar 

Elmorshedy H, Tanner M, Bergquist RN, Sharaf S, Barakat R. Prophylactic effect of artemether on human schistosomiasis mansoni among Egyptian children: a randomized controlled trial. Acta Trop. 2016;158:52–8.

Article  CAS  PubMed  Google Scholar 

Inyang-Etoh PC, Ejezie GC, Useh MF, Inyang-Etoh EC. Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria. Trans R Soc Trop Med Hyg. 2009;103(1):38–44.

Article  CAS  PubMed  Google Scholar 

Mnkugwe RH, Minzi O. Kinung’hi S, Kamuhabwa A, Aklillu E: Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: a randomized, non-inferiority clinical trial. PLoS Negl Trop Dis. 2020;14(9):1–18.

Article